openPR Logo
Press release

Meningococcal Vaccines Market by Type, End-user and Geography. Market Leaders are GlaxoSmithKline, JN-International Medical Corporation, Novartis, Sanofi, Pfizer, and Baxter

Meningococcal Vaccines Market by Type, End-user and Geography.

Meningococcal disease is a fatal disease caused by a bacteria called as Neisseria Meningitides which cause potential infection in the meninges, the thin layers of connective tissues which surrounds spinal cord and brain.

Factors which are playing important role in the growth of meningococcal vaccines are-
• Increases incidence of meningococcal disease
• Growing awareness about availability of its vaccines
• Government based initiatives
• Increased R & D investments by different players with introduction of advanced vaccines are leading the growth of meningococcal vaccines market.

However, vaccines cost, lack of awareness about the disease and stringent regulatory policies are huge restraints in the global meningococcal vaccines market.

Market summary:
With encouraging government initiatives, the global market for meningococcal diseases is growing at expedited rate. The meningococcal vaccine market has very limited numbers of market players and is expecting a lot of new entries in the near future. With increasing awareness about the disease and availability of vaccine, MenA joined hands with other vaccine programs in Africa to prevent around 123000 deaths in 2018.

Regional Analysis
In the global meningococcal vaccines market, North America holds the strongest position followed by Europe. Factors such as population surge, increased cases of meningococcal diseases accounts for account share. In Europe, Germany, UK and France hold the largest share due to great healthcare facilities and government bases initiatives. Asia Pacific is showing a substantial growth due to disposable income, different government immunization to eradicate meningococcal diseases.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/meningococcal-vaccines-market/

Notable market development
TRUMENBA (meningococcal group B vaccine) from Pfizer received approval from US FDA in 2014 to prevent meningococcal vaccine.

Some of the key market players in the global meningococcal vaccines market are-
• GlaxoSmithKline plc. (UK)
• JN-International Medical Corporation (U.S.)
• Novartis International AG (Switzerland)
• Sanofi (France)
• Pfizer, Inc. (U.S.)
• Baxter International, Inc. (U.S.)

Avail free sample report at https://bit.ly/2FWDDd8

The global meningococcal vaccines market is divided into following categories-

By type
• Meningococcal Conjugate Vaccines
• Meningococcal Polysaccharide Vaccine
• Serogroup B Meningococcal Vaccine

By end-users
• Hospitals
• Clinic
• Others

By geographical regions
• North America
• Latin America
• Europe
• Asia-Pacific
• The Middle East & Africa

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningococcal Vaccines Market by Type, End-user and Geography. Market Leaders are GlaxoSmithKline, JN-International Medical Corporation, Novartis, Sanofi, Pfizer, and Baxter here

News-ID: 1428845 • Views:

More Releases from Precision Business Insights

Biochar Market Growth Is Attributed To The Increased Production Of Biochar Through Pyrolysis Technology
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Membrane Separation Technology
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Generation
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater

All 5 Releases


More Releases for Meningococcal

Meningococcal Vaccines Market
Meningococcal Vaccines Market 2022 The Meningococcal Vaccines Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire
Meningococcal Vaccines Market Report Up to 2031
Visiongain has published a new report on Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/meningococcal-vaccines-market-2021/#download_sampe_div Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations
Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of
Meningococcal Vaccines Market | Rising Incidence of Meningococcal Disease Propel …
The global Meningococcal Vaccines Market consists of a good number of established players who are on a quest to expand their market shares. The competition in the market has been stiffening over the past decade, partly due to the innovative business strategies of leading players, and majorly on account of the continual entry of new players. The companies operating in the pharmaceutical industry can easily expand their horizons by manufacturing
Meningococcal Vaccines Market: Regional & Competitive Analysis
A new Transparency Market Research report states that the global meningococcal vaccines market stood at US$1.5 bn in 2013 and is predicted to reach US$4.4 bn in 2022. It is expected to expand at a CAGR of 12.40% from 2014 to 2022. The title of the report is “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022”. View Full Report: http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html As per the